Cargando…

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers

Currently, no disease modifying therapies (DMTs) have been approved for use in dementia with Lewy bodies (DLB). Clinical trials face difficulties due to the clinical and neuropathological heterogeneity of the condition with a diverse array of neuropathogenic mechanisms contributing to the clinical p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibson, Lucy L., Abdelnour, Carla, Chong, Joyce, Ballard, Clive, Aarsland, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	NEUROIMAGING: Edited by Massimo Filippi
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328538/ https://www.ncbi.nlm.nih.gov/pubmed/37387459 http://dx.doi.org/10.1097/WCO.0000000000001173

Ejemplares similares

Defining the presymptomatic phase of frontotemporal dementia
por: Russell, Lucy L., et al.
Publicado: (2023)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
por: Howlett, David R., et al.
Publicado: (2014)

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
por: Tan, Rachel H., et al.
Publicado: (2017)

Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia
por: Bocchetta, Martina, et al.
Publicado: (2019)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias
por: Xing, Huayang, et al.
Publicado: (2016)

The importance of co-pathologies on neuropsychiatric symptoms in dementia
por: Gibson, Lucy L., et al.
Publicado: (2022)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia
por: Vallortigara, Julie, et al.
Publicado: (2014)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland
por: Ciblis, Aurelia S., et al.
Publicado: (2015)

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia
por: Nazem, Amir, et al.
Publicado: (2018)

Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ(42), phosphorylated α‐synuclein, and synaptopathology
por: Chong, Joyce R., et al.
Publicado: (2023)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2022)

Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: A systematic review
por: Pellegrini, Enrico, et al.
Publicado: (2018)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

White matter microstructure disruption in early stage amyloid pathology
por: Collij, Lyduine E., et al.
Publicado: (2021)

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline
por: Verfaillie, Sander C.J., et al.
Publicado: (2016)

Locus coeruleus MRI contrast is reduced in Alzheimer's disease dementia and correlates with CSF Aβ levels
por: Betts, Matthew J., et al.
Publicado: (2019)

Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
por: Nimmo, Jacqui, et al.
Publicado: (2020)

Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment
por: Pascoal, Tharick A., et al.
Publicado: (2020)

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors
por: Raman, Mekala R., et al.
Publicado: (2016)

Adenoma sebaceum: Dermatological finding unmasking central nervous system pathology
por: Krishnan, Prasad, et al.
Publicado: (2016)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2022)

Computationally derived anatomic subtypes of behavioral variant frontotemporal dementia show temporal stability and divergent patterns of longitudinal atrophy
por: Ranasinghe, Kamalini G., et al.
Publicado: (2021)

A guide for researchers seeking training in retrospective data harmonization for population neuroscience studies of Alzheimer's disease and related dementias
por: Shaaban, C. Elizabeth, et al.
Publicado: (2022)

In vivo network models identify sex differences in the spread of tau pathology across the brain
por: Shokouhi, Sepideh, et al.
Publicado: (2020)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Spatio‐spectral relationships between pathological neural dynamics and cognitive impairment along the Alzheimer's disease spectrum
por: Wiesman, Alex I., et al.
Publicado: (2021)

Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode network
por: Rane, Swati, et al.
Publicado: (2018)

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging
por: Leijenaar, Jolien F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cq8grjj9oh2amih6nig2da7g7h